Table 2 PC-594 statistical performance in USA Caucasian populations
From: Metabolic system alterations in pancreatic cancer patient serum: potential for early detection
Cohort | Mean PC-594 (ug/ml CAE) ±1SEM | p versus PC | ROC-AUC versus PC (95% CI) |
|---|---|---|---|
USA control 1 | Â | Â | Â |
  30-39 yrs | 2.85 ±0.14 | 4.8E-09 | 0.99 (0.98-1.0) |
  40-49 yrs | 2.58 ±0.09 | 5.7E-07 | 0.97 (0.96-0.98) |
  50-59 yrs | 2.44 ±0.12 | 1.8E-05 | 0.97 (0.96-0.98) |
  60-69 yrs | 1.77 ±0.10 | 1.9E-05 | 0.91 (0.89-0.93) |
  70-80 yrs | 1.69 ±0.09 | 7.9E-04 | 0.90 (0.88-0.92) |
  All yrs | 2.23 ±0.05 | 6.2E-05 | 0.94 (0.93-0.96) |
USA control 2 | 2.15 ±0.20 | 5.9E-06 | 0.97 (0.95-0.99) |
USA IMPN | 0.95 ±0.19 | 0.003 | - |
USA PC | 0.43 ±0.06 | - | - |